HMMJ:CA:TSX-Global X Marijuana Life Sciences Index ETF (CAD)

ETF | Sector Equity |

Last Closing

CAD 9.23

Change

0.00 (0.00)%

Market Cap

CAD 0.07B

Volume

0.02M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-12-26 )

Largest Industry Peers for Sector Equity

Symbol Name Price(Change) Market Cap
TEC:CA TD Global Technology Leaders I..

-0.52 (-1.09%)

CAD 3.43B
ZWU:CA BMO Covered Call Utilities ETF

-0.02 (-0.19%)

CAD 1.81B
XIT:CA iShares S&P/TSX Capped Informa..

-0.44 (-0.63%)

CAD 0.78B
HTA:CA Harvest Tech Achievers Growth ..

-0.22 (-1.14%)

CAD 0.68B
TXF:CA First Asset Tech Giants Covere..

-0.23 (-1.07%)

CAD 0.67B
XHC:CA iShares Global Healthcare (CAD..

-0.07 (-0.10%)

CAD 0.54B
ZUT:CA BMO Equal Weight Utilities Ind..

-0.04 (-0.18%)

CAD 0.51B
XUT:CA iShares S&P/TSX Capped Utiliti..

-0.04 (-0.14%)

CAD 0.37B
CWW:CA iShares Global Water Common Cl..

-0.07 (-0.12%)

CAD 0.31B
COW:CA iShares Global Agriculture Com..

+0.23 (+0.35%)

CAD 0.27B

ETFs Containing HMMJ:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Sector Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -0.65% 23% F 20% F
Dividend Return 2.90% 62% D 42% F
Total Return 2.25% 20% F 19% F
Trailing 12 Months  
Capital Gain -2.22% 23% F 18% F
Dividend Return 2.85% 62% D 41% F
Total Return 0.63% 20% F 17% F
Trailing 5 Years  
Capital Gain -73.14% 6% D- 7% C-
Dividend Return 12.84% 67% D+ 34% F
Total Return -60.30% 6% D- 8% B-
Average Annual (5 Year Horizon)  
Capital Gain 2.84% 23% F 44% F
Dividend Return 4.92% 29% F 46% F
Total Return 2.08% 70% C- 62% D
Risk Return Profile  
Volatility (Standard Deviation) 45.56% 11% F 20% F
Risk Adjusted Return 10.80% 9% A- 28% F
Market Capitalization 0.07B 44% F 29% F

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.